Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1585, 2007-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Validity of Cost and Utility Results?
PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. :
Access to resources
Recommend
Prescribing HRT to change following trial results?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
Ramipril preferable in hypertensive nephrosclerosis?
Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. :
A ready remedy for rheumatoid arthritis realised in R 788 results?
Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. :
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :